Literature DB >> 14723619

The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis.

T E Michaelsen1, J Kolberg, A Aase, T K Herstad, E A Høiby.   

Abstract

Mouse monoclonal antibodies (MoAbs) of the four IgG isotypes, all specific for the P1.16 epitope on the meningcoccal PorA protein, were tested for functional activities. The avidities of the antibodies, measured by NH4SCN elution in enzyme-linked immunosorbent assay, showed similar values for all the MoAbs. The serum bactericidal activity (SBA) defined as the lowest concentration of antibodies giving 50% reduction in the number of meningococcal colony-forming units using human serum as complement, showed a hierarchy of IgG3 >> IgG2b > IgG2a >> IgG1. For the opsonophagocytosis (OP), the hierarchy was IgG3 > IgG2b = IgG2a >> IgG1. OP was measured in flow cytometry using log-phase live meningococci as target cells, normal human peripheral blood polymorphonuclear cells (PMNs) as effector cells and human serum as a complement source. The mouse MoAbs were negative in OP when using human PMNs in the absence of complement. The results demonstrate the importance of choosing the right isotype of mouse MoAbs when using them to judge the potential vaccine importance of their corresponding antigen. If such MoAbs should be used for passive vaccination against infectious diseases, the isotype would presumably play an important role for their anticipated clinical effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14723619     DOI: 10.1111/j.0300-9475.2004.01362.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  31 in total

1.  Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Shawn M Zimmerman; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

2.  A listeriolysin O subunit vaccine is protective against Listeria monocytogenes.

Authors:  Christopher C Phelps; Stephen Vadia; Prosper N Boyaka; Sanjay Varikuti; Zayed Attia; Purnima Dubey; Abhay R Satoskar; Rodney Tweten; Stephanie Seveau
Journal:  Vaccine       Date:  2020-07-17       Impact factor: 3.641

Review 3.  Cancer vaccines and carbohydrate epitopes.

Authors:  Jamie Heimburg-Molinaro; Michelle Lum; Geraldine Vijay; Miten Jain; Adel Almogren; Kate Rittenhouse-Olson
Journal:  Vaccine       Date:  2011-10-01       Impact factor: 3.641

4.  Antibody response specific to the capsular polysaccharide is impaired in Streptococcus suis serotype 2-infected animals.

Authors:  Cynthia Calzas; Paul Lemire; Gael Auray; Volker Gerdts; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

5.  Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo.

Authors:  Robert A Fenstermaker; Sheila A Figel; Jingxin Qiu; Tara A Barone; Sanam S Dharma; Evan K Winograd; Phillip M Galbo; Laura M Wiltsie; Michael J Ciesielski
Journal:  Clin Cancer Res       Date:  2018-03-14       Impact factor: 12.531

6.  Immunization with recombinant Sao protein confers protection against Streptococcus suis infection.

Authors:  Yuanyi Li; Marcelo Gottschalk; Miriam Esgleas; Sonia Lacouture; J Daniel Dubreuil; Philip Willson; Josee Harel
Journal:  Clin Vaccine Immunol       Date:  2007-06-13

7.  Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.

Authors:  Guillaume Goyette-Desjardins; Cynthia Calzas; Tze Chieh Shiao; Axel Neubauer; Jennifer Kempker; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

8.  Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity.

Authors:  Serena Giuntini; Peter T Beernink; Donald C Reason; Dan M Granoff
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

9.  Phytol-based novel adjuvants in vaccine formulation: 2. Assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice.

Authors:  So-Yon Lim; Adam Bauermeister; Richard A Kjonaas; Swapan K Ghosh
Journal:  J Immune Based Ther Vaccines       Date:  2006-10-23

10.  IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections.

Authors:  Y-Y Wang; A Kannan; K L Nunn; M A Murphy; D B Subramani; T Moench; R Cone; S K Lai
Journal:  Mucosal Immunol       Date:  2014-02-05       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.